TRAVIS EWING: Open Payments
NPI 1376980367 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 86 payments from 14 companies in 2025. Trend: 2023 $981 · 2024 $1,042 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 33 | $260 |
| ABBVIE INC. | 20 | $252 |
| AstraZeneca Pharmaceuticals LP | 6 | $251 |
| Lilly USA, LLC | 9 | $140 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| SHIELD THERAPEUTICS INC | 1 | $31 |
| Phathom Pharmaceuticals, Inc. | 8 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Dexcom, Inc. | 1 | $19 |
| Edwards Lifesciences Corporation | 1 | $19 |
Products named: AIRSUPRA, NURTEC ODT, MOUNJARO, QULIPTA, UBRELVY, ELIQUIS, TRELEGY ELLIPTA, VRAYLAR.
Industry payments across AR — which companies pay providers there.
